Ali Behbahani Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ali Behbahani.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).

Latest Insider Trading Transactions of Ali Behbahani

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 22 2021	BDTX	Black Diamond Ther ...	Behbahani Ali	Director	Grant	A	24.01	547	13,133	547	0 to 547
Mar 18 2021	MRKR	Marker Therapeutic ...	Behbahani Ali	10% Owner	Buy	P	1.75	5,714,285	9,999,999	10,714,285	5 M to 10.7 M (+114.29 %)
Dec 07 2020	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	0.00	258,707	0	258,707
Dec 07 2020	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	0.75	5,239,254	3,910,579	5,239,254
Dec 07 2020	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Buy	P	0.62	4,398,602	2,735,930	6,451,056	2.1 M to 6.5 M (+214.31 %)
Sep 22 2020	MTCR	Metacrine, Inc.	Behbahani Ali	10% Owner	Option Exercise	C	0.00	332,964	0	0
Sep 22 2020	MTCR	Metacrine, Inc.	Behbahani Ali	10% Owner	Option Exercise	C	0.00	1,958,333	0	0
Sep 22 2020	MTCR	Metacrine, Inc.	Behbahani Ali	10% Owner	Buy	P	13.00	769,230	9,999,990	3,060,527	2.3 M to 3.1 M (+33.57 %)
Sep 22 2020	MTCR	Metacrine, Inc.	Behbahani Ali	10% Owner	Buy	C	0.00	332,964	0	2,291,297	2 M to 2.3 M (+17.00 %)
Sep 22 2020	MTCR	Metacrine, Inc.	Behbahani Ali	10% Owner	Buy	C	0.00	1,958,333	0	1,958,333	0 to 2 M
Aug 14 2020	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Buy	J	0.00	14	0	14	0 to 14
Aug 14 2020	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Buy	J	0.00	57	0	256	199 to 256 (+28.64 %)
Jul 28 2020	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Option Exercise	P	2.25	3,151,260	7,090,335	3,151,260
Jul 28 2020	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Buy	P	2.25	3,151,260	7,090,335	10,376,936	7.2 M to 10.4 M (+43.61 %)
Jul 13 2020	NKTX	Nkarta, Inc.	Behbahani Ali	Director	Option Exercise	A	18.00	10,700	192,600	10,700
Jul 13 2020	NKTX	Nkarta, Inc.	Behbahani Ali	Director	Option Exercise	A	18.00	10,700	192,600	10,700
Jul 01 2020	AKUS	Akouos, Inc.	Behbahani Ali	10% Owner	Option Exercise	C	0.00	1,199,976	0	0
Jul 01 2020	AKUS	Akouos, Inc.	Behbahani Ali	10% Owner	Option Exercise	C	0.00	1,992,238	0	0
Jul 01 2020	AKUS	Akouos, Inc.	Behbahani Ali	10% Owner	Option Exercise	C	0.00	513,758	0	0
Jul 01 2020	AKUS	Akouos, Inc.	Behbahani Ali	10% Owner	Buy	P	17.00	588,235	9,999,995	4,294,207	3.7 M to 4.3 M (+15.87 %)
Jul 01 2020	AKUS	Akouos, Inc.	Behbahani Ali	10% Owner	Buy	C	0.00	1,199,976	0	3,705,972	2.5 M to 3.7 M (+47.88 %)
Jul 01 2020	AKUS	Akouos, Inc.	Behbahani Ali	10% Owner	Buy	C	0.00	1,992,238	0	2,505,996	513.8 K to 2.5 M (+387.78 %)
Jul 01 2020	AKUS	Akouos, Inc.	Behbahani Ali	10% Owner	Buy	C	0.00	513,758	0	513,758	0 to 513.8 K
Jul 01 2020	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Option Exercise	A	1.67	184,258	307,711	184,258
Jun 19 2020	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Option Exercise	A	2.22	15,000	33,300	15,000
Jun 15 2020	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Option Exercise	A	59.70	15,000	895,500	15,000
Jun 10 2020	OYST	Oyster Point Pharm ...	Behbahani Ali	Director	Grant	A	0.00	6,600	0	6,600	0 to 6.6 K
Jun 10 2020	OYST	Oyster Point Pharm ...	Behbahani Ali	Director	Grant	A	0.00	6,600	0	6,600	0 to 6.6 K
Apr 13 2020	TRVI	Trevi Therapeutics ...	Behbahani Ali	10% Owner	Option Exercise	X	0.00	1,500,000	1,500	0
Apr 13 2020	TRVI	Trevi Therapeutics ...	Behbahani Ali	10% Owner	Sell	S	2.66	564	1,500	5,937,998	5.9 M to 5.9 M (-0.01 %)
Apr 13 2020	TRVI	Trevi Therapeutics ...	Behbahani Ali	10% Owner	Buy	X	0.00	1,500,000	1,500	5,938,562	4.4 M to 5.9 M (+33.79 %)
Feb 05 2020	BDTX	Black Diamond Ther ...	Behbahani Ali	Director	Option Exercise	C	0.00	1,422,862	0	0
Feb 05 2020	BDTX	Black Diamond Ther ...	Behbahani Ali	Director	Option Exercise	C	0.00	6,565,290	0	0
Feb 05 2020	BDTX	Black Diamond Ther ...	Behbahani Ali	Director	Buy	P	19.00	800,000	15,200,000	3,448,757	2.6 M to 3.4 M (+30.20 %)
Feb 05 2020	BDTX	Black Diamond Ther ...	Behbahani Ali	Director	Buy	C	0.00	471,800	0	2,648,757	2.2 M to 2.6 M (+21.67 %)
Feb 05 2020	BDTX	Black Diamond Ther ...	Behbahani Ali	Director	Buy	C	0.00	2,176,957	0	2,176,957	0 to 2.2 M
Jan 28 2020	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Buy	P	0.67	7,500,000	5,000,250	19,500,000	12 M to 19.5 M (+62.50 %)
Dec 26 2019	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	0.00	900,900	0	900,900
Dec 26 2019	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	0.67	9,009,000	5,999,994	9,009,000
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	Behbahani Ali	10% Owner	Option Exercise	C	0.00	29,889,945	0	0
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	Behbahani Ali	10% Owner	Option Exercise	C	0.00	29,889,945	0	0
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	Behbahani Ali	10% Owner	Buy	P	15.00	450,000	6,750,000	4,186,243	3.7 M to 4.2 M (+12.04 %)
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	Behbahani Ali	10% Owner	Buy	P	15.00	450,000	6,750,000	4,186,243	3.7 M to 4.2 M (+12.04 %)
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	Behbahani Ali	10% Owner	Buy	C	0.00	3,736,243	0	3,736,243	0 to 3.7 M
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	Behbahani Ali	10% Owner	Buy	C	0.00	3,736,243	0	3,736,243	0 to 3.7 M
Jul 19 2019	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Option Exercise	A	3.66	5,625	20,588	5,625
Jul 03 2019	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Option Exercise	A	0.61	234,407	142,988	234,407
Jun 25 2019	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Buy	P	3.50	2,857,142	9,999,997	7,225,676	4.4 M to 7.2 M (+65.40 %)
Jun 25 2019	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Buy	P	3.50	2,857,142	9,999,997	7,225,676	4.4 M to 7.2 M (+65.40 %)
Jun 13 2019	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Option Exercise	A	43.52	15,000	652,800	15,000
May 13 2019	TRVI	Trevi Therapeutics ...	Behbahani Ali	10% Owner	Option Exercise	C	0.00	17,099,315	0	0
May 13 2019	TRVI	Trevi Therapeutics ...	Behbahani Ali	10% Owner	Buy	P	10.00	1,500,000	15,000,000	4,438,562	2.9 M to 4.4 M (+51.05 %)
May 13 2019	TRVI	Trevi Therapeutics ...	Behbahani Ali	10% Owner	Buy	P	10.00	1,000,000	10,000,000	2,938,562	1.9 M to 2.9 M (+51.58 %)
May 13 2019	TRVI	Trevi Therapeutics ...	Behbahani Ali	10% Owner	Buy	C	0.00	1,938,562	0	1,938,562	0 to 1.9 M
May 09 2019	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	0.00	256,700	0	256,700
May 09 2019	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	1.08	3,703,704	4,000,000	3,703,704
May 09 2019	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Buy	P	1.08	1,136,704	1,227,640	2,052,454	915.8 K to 2.1 M (+124.13 %)
Feb 19 2019	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Option Exercise	P	0.57	2,487,067	1,406,685	2,487,067
Feb 19 2019	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Buy	P	0.47	9,948,269	4,688,619	34,948,269	25 M to 34.9 M (+39.79 %)
Sep 10 2018	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Buy	P	1.67	12,000,000	20,000,400	12,000,000	0 to 12 M
Jun 26 2018	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Option Exercise	A	2.18	154,809	337,484	154,809
Jun 25 2018	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Option Exercise	A	0.99	50,000	49,500	50,000
Jun 15 2018	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Option Exercise	A	59.31	15,000	889,650	15,000
Jun 15 2018	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Option Exercise	A	59.31	15,000	889,650	15,000
May 23 2018	NVRO	NEVRO CORP	Behbahani Ali	Director	Grant	A	0.00	3,785	0	5,390	1.6 K to 5.4 K (+235.83 %)
May 23 2018	NVRO	NEVRO CORP	Behbahani Ali	Director	Grant	A	0.00	3,785	0	5,390	1.6 K to 5.4 K (+235.83 %)
Feb 12 2018	GNCA	GENOCEA BIOSCIENCE ...	Behbahani Ali	Director	Option Exercise	A	0.98	25,000	24,500	25,000
Sep 15 2017	NVRO	NEVRO CORP	Behbahani Ali	Director	Buy	J	0.00	8	0	1,605	1.6 K to 1.6 K (+0.50 %)
Sep 15 2017	NVRO	NEVRO CORP	Behbahani Ali	Director	Buy	J	0.00	32	0	1,597	1.6 K to 1.6 K (+2.04 %)
Jul 03 2017	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Option Exercise	A	0.75	220,788	165,591	220,788
Jun 02 2017	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Option Exercise	A	13.62	15,000	204,300	15,000
May 30 2017	NVRO	NEVRO CORP	Behbahani Ali	Director	Option Exercise	A	74.07	3,545	262,578	3,545
May 30 2017	NVRO	NEVRO CORP	Behbahani Ali	Director	Grant	A	0.00	1,518	0	1,565	47 to 1.6 K (+3,229.79 %)
Nov 15 2016	NVRO	NEVRO CORP	Behbahani Ali	Director	Buy	J	0.00	3	0	47	44 to 47 (+6.82 %)
Nov 15 2016	NVRO	NEVRO CORP	Behbahani Ali	Director	Buy	J	0.00	19	0	44	25 to 44 (+76.00 %)
Oct 20 2016	CRSP	CRISPR Therapeutic ...	Behbahani Ali	Director	Option Exercise	A	14.00	30,000	420,000	30,000
Aug 12 2016	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Option Exercise	A	1.27	184,562	234,394	184,562
May 20 2016	NVRO	NEVRO CORP	Behbahani Ali	Director	Option Exercise	A	63.39	3,240	205,384	3,240
Dec 03 2015	NVRO	NEVRO CORP	Behbahani Ali	Director	Buy	J	0.00	3	0	25	22 to 25 (+13.64 %)
Dec 03 2015	NVRO	NEVRO CORP	Behbahani Ali	Director	Buy	J	0.00	22	0	22	0 to 22
Jun 01 2015	NVRO	NEVRO CORP	Behbahani Ali	Director	Option Exercise	A	50.50	4,182	211,191	4,182
Nov 07 2014	NVRO	NEVRO CORP	Behbahani Ali	Director	Option Exercise	A	18.00	8,477	152,586	8,477

Page: 1